REQUEST A DEMO
Total
USD $0.00
Search more companies

Annji Pharmaceutical Co. Ltd. (Taiwan, China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Annji Pharmaceutical Co. Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Annji Pharmaceutical Co. Ltd. is an enterprise located in Taiwan, China, with the main office in Taipei City. The company operates in the Pharmaceutical Preparation Manufacturing sector. Annji Pharmaceutical Co. Ltd. was incorporated on April 12, 2026. In Q2C2025, the company reported a net sales revenue drop of 91.05%. A negative growth of 30.42% was recorded in its total assets. The net profit margin of Annji Pharmaceutical Co. Ltd. decreased by 1985.95% in 2025.

Headquarters
16F.-6, No. 508, Sec. 7, Zhongxiao E. Rd Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Annji Pharmaceutical Co. Ltd. report to view the information.

Website: http://www.ajpharm.com

Basic Information
Outstanding Shares:
Purchase the Annji Pharmaceutical Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Annji Pharmaceutical Co. Ltd. report to view the information.
Incorporation Date:
April 12, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Executive Vice President
Ownership Details
Purchase this report to view the information.
16.54%
Purchase this report to view the information.
9.87%
Purchase this report to view the information.
5.75%
Purchase this report to view the information.
4.49%
Purchase this report to view the information.
2.72%
Company Performance
Financial values in the chart are available after Annji Pharmaceutical Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-91.05%
Total Operating Revenue
-90.62%
Operating Profit
11.44%
EBITDA
11.21%
Net Profit/Loss for the Period
18.8%
Total Assets
-30.42%
Total Equity
-36.96%
Operating Profit Margin
-2249.49%
Net Profit Margin
-1985.95%
Return on Equity (ROE)
-6.98%
Debt / Equity
3066%
Quick Ratio
1656.58%
Cash Ratio
1.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?